Comparison between drug-eluting stents for the treatment of the diffuse type in-stent restenosis after drug-eluting stents implantation: sirolimus-eluting vs. paclitaxel-eluting stents
Phase of Trial: Phase IV
Latest Information Update: 07 Aug 2012
At a glance
- Drugs Sirolimus (Primary) ; Paclitaxel
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms DES-ISR
- 07 Aug 2012 Actual end date (1 Oct 2011) added as reported by ClinicalTrials.gov.
- 01 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Aug 2007 New trial record.